Paper30191007
Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.
Brunt EM and 3 others. Hepat Oncol, 2015. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Papers, record 30191007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30191007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19150350 | EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19150350 | PubMed |
| 2 | 18454509 | The hepatic stem cell niche: identification by label-retaining cell assay. | Hepatology | 2008 | https://conductscience.org/library/papers/18454509 | PubMed |
| 3 | 14556657 | Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. | Cancer Sci | 2003 | https://conductscience.org/library/papers/14556657 | PubMed |
| 4 | 12940779 | Hepatic 'stem cell' malignancies in adults: four cases. | Histopathology | 2003 | https://conductscience.org/library/papers/12940779 | PubMed |
| 5 | 8666372 | Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. | Hum Pathol | 1996 | https://conductscience.org/library/papers/8666372 | PubMed |
| 6 | 16879391 | The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. | Histopathology | 2006 | https://conductscience.org/library/papers/16879391 | PubMed |
| 7 | 23523670 | Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23523670 | PubMed |
| 8 | 12170085 | Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. | Am J Surg Pathol | 2002 | https://conductscience.org/library/papers/12170085 | PubMed |
| 9 | 21344355 | Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. | Semin Liver Dis | 2011 | https://conductscience.org/library/papers/21344355 | PubMed |
| 10 | 23958557 | Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. | Gut | 2014 | https://conductscience.org/library/papers/23958557 | PubMed |
| 11 | 23726876 | Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23726876 | PubMed |
| 12 | 21501296 | Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. | Pathol Int | 2011 | https://conductscience.org/library/papers/21501296 | PubMed |
| 13 | 23397471 | Combined hepatocellular cholangiocarcinoma: a case report and review of literature. | Dig Dis Sci | 2013 | https://conductscience.org/library/papers/23397471 | PubMed |
| 14 | 24633664 | Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy. | Ann Surg Oncol | 2014 | https://conductscience.org/library/papers/24633664 | PubMed |
| 15 | 2578078 | Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. | Cancer | 1985 | https://conductscience.org/library/papers/2578078 | PubMed |
| 16 | 18393293 | Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. | Hepatology | 2008 | https://conductscience.org/library/papers/18393293 | PubMed |
| 17 | 12927921 | Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. | J Hepatol | 2003 | https://conductscience.org/library/papers/12927921 | PubMed |
| 18 | 23388123 | Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. | Am J Surg Pathol | 2013 | https://conductscience.org/library/papers/23388123 | PubMed |
| 19 | 10870076 | World Health Organization classification of tumors. | Cancer | 2000 | https://conductscience.org/library/papers/10870076 | PubMed |
| 20 | 11182037 | Clinicopathologic study on cholangiolocellular carcinoma. | Oncol Rep | 2001 | https://conductscience.org/library/papers/11182037 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42101525 | Radiogenomics deciphers tumor heterogeneity in hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42101525 | PubMed |
| 40809514 | A Case of Combined Hepatocellular-Cholangiocarcinoma Diagnosis and Treatment With Literature Review. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/40809514 | PubMed |
| 40502515 | Liver transplantation for combined hepatocellular cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies. | World J Gastrointest Surg | 2025 | https://conductscience.org/library/papers/40502515 | PubMed |
| 38780656 | Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38780656 | PubMed |
| 38278146 | Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38278146 | PubMed |
| 36009374 | Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009374 | PubMed |
| 35459975 | Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma. | Virchows Arch | 2022 | https://conductscience.org/library/papers/35459975 | PubMed |
| 33102226 | Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/33102226 | PubMed |
| 32729276 | Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis. | Korean J Radiol | 2020 | https://conductscience.org/library/papers/32729276 | PubMed |
| 32190288 | Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features. | Cell Biosci | 2020 | https://conductscience.org/library/papers/32190288 | PubMed |
| 31654212 | Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors. | Eur Radiol | 2020 | https://conductscience.org/library/papers/31654212 | PubMed |
| 30519546 | Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist. | J Hepatocell Carcinoma | 2018 | https://conductscience.org/library/papers/30519546 | PubMed |
| 30191013 | Hepatic stem cells and cancers: a pathologist's view. | Hepat Oncol | 2015 | https://conductscience.org/library/papers/30191013 | PubMed |
| 29360137 | cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. | Hepatology | 2018 | https://conductscience.org/library/papers/29360137 | PubMed |
| 29270746 | Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma. | J Huazhong Univ Sci Technolog Med Sci | 2017 | https://conductscience.org/library/papers/29270746 | PubMed |
| 29131160 | Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. | Nat Med | 2017 | https://conductscience.org/library/papers/29131160 | PubMed |
| 28839428 | From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. | World J Gastroenterol | 2017 | https://conductscience.org/library/papers/28839428 | PubMed |
| 28707055 | Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series. | Virchows Arch | 2017 | https://conductscience.org/library/papers/28707055 | PubMed |
| 28261592 | Pathology of intrahepatic cholangiocarcinoma. | Hepatobiliary Surg Nutr | 2017 | https://conductscience.org/library/papers/28261592 | PubMed |
| 26441248 | Regenerative medicine: Hepatic progenitor cells up their game in the therapeutic stakes. | Nat Rev Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/26441248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30191007
GET https://conductscience.org/api/papers/v1/30191007/references?page=2